MedTrace Logo

Emergence Times and Airway Reactions in General Laryngeal Mask Airway Anesthesia

NCT02322502 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 352

Last updated 2016-10-06

No results posted yet for this study

Summary

The aim of this study is first to assess if desflurane is superior in order to achieve a faster emergence from anesthesia.

Conditions

  • Anesthesia With Use of LMA (Laryngeal Mask Airway)

Interventions

DRUG

Desflurane

inhalation with laryngeal mask to maintain anaesthesia

DRUG

Sevoflurane

inhalation with laryngeal mask to maintain anaesthesia

DRUG

propofol

intravenous injection to maintain anaesthesia

Sponsors & Collaborators

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Mark Coburn, Prof. · University Hospital, Aachen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02322502 on ClinicalTrials.gov